MolNFT v1 · #141137 · protein
A ligand F binding to fxr
5YXD · Bile acid receptor: “A ligand F binding to fxr”. X-ray diffraction, 1 ligand (93R), 2 pockets (best druggability 0.86). MolNFT v1 #141137 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5YXD
- Type
- protein
- Length
- 240 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Bile acid receptor; Peptide from nuclear receptor coactivator
- UniProt
- Q96RI1
- Ligands
- 93R
- Pockets
- 2 · best druggability 0.86
Structure
x-ray diffraction · 2 distinct chains · 73% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Bile acid receptor | protein | 229 | 73% helix, 0% strand | Q96RI1 |
| B | Peptide from nuclear receptor coactivator | protein | 11 | 73% helix, 0% strand | — |
Ligands and binding sites
- 93R · ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 318 | 0.86 | 0.95 | 31 | 93R |
| 2 | 150 | 0.41 | 0.74 | 19 | empty |
Interfaces
1 interface between chains.
- A–B · 578 Ų buried · 8 hydrogen bonds · protein-protein
Compared structures
- 5YXD · A ligand F binding to FXR · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q96RI1
- Elsewhere: RCSB PDB 5YXD · PDBe 5YXD · UniProt Q96RI1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.